Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001327598 | SCV001518682 | uncertain significance | MHC class I deficiency | 2022-07-13 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 7 of the TAP2 gene. It does not directly change the encoded amino acid sequence of the TAP2 protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs773119824, gnomAD 0.004%). This variant has not been reported in the literature in individuals affected with TAP2-related conditions. ClinVar contains an entry for this variant (Variation ID: 1027053). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |